Urine α-fetoprotein and orosomucoid 1 as biomarkers of hepatitis B virus-associated hepatocellular carcinoma

被引:29
|
作者
Zhan, Zhu [1 ,2 ,3 ]
Guan, Yalan [1 ,2 ,3 ]
Mew, Kenley [4 ]
Zeng, Weigiong [1 ,2 ,3 ]
Peng, Mingli [1 ,2 ,3 ]
Hu, Peng [1 ,2 ,3 ]
Yang, Yixuan [1 ,2 ,3 ]
Lu, Yi [1 ,2 ,3 ]
Ren, Hong [1 ,2 ,3 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 2, Dept Infect Dis, Chongqing, Peoples R China
[2] Chongqing Med Univ, Inst Viral Hepatitis, Chongqing, Peoples R China
[3] Chongqing Med Univ, Key Lab Mol Biol Infect Dis, Minist Educ, Chongqing, Peoples R China
[4] Chongqing Med Univ, Dept Foreign Language, Chongqing, Peoples R China
关键词
biomarker; hepatocellular carcinoma; proteomic; urine; alpha-fetoprotein; CLINICAL-PRACTICE GUIDELINES; ALPHA-1-ACID GLYCOPROTEIN; PROTEIN; COMBINATION; MANAGEMENT;
D O I
10.1152/ajpgi.00267.2019
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatocellular carcinoma (HCC) is the sixth common malignant tumor worldwide. but current efficient and convenient screening methods remain lacking. This study aimed to discover a diagnostic or a screening biomarker from the urine of hepatitis B virus (HBV)-related HCC patients. We used iTRAQ coupled with mass spectrometry to identify candidate urinary proteins in a discovery cohort (n = 40). The selected proteins were confirmed using ELISA in a validation cohort (n = 140). Diagnostic performance of the selected proteins was assessed using receiver operating characteristic (ROC) and qualitative diagnostic analysis. A total of 96 differentially expressed proteins were identified. Urinary alpha-fetoprotein (u-AFP) and orosomucoid 1 (u-ORM1) were selected as target proteins by bioinformatics analysis and were significantly higher in HCC than in non-HCC patients, as validated by Western blot analysis and ELISA. u-AFP had a strong correlation with serum AFP-L3 (Pearson's r = 0.944, P < 0.0001), indicating that u-AFP may be derived from circulating blood. The area under the curve (AUC) of u-AFP was 0.795 with a sensitivity of 62.5% and a specificity of 95.4%, which showed no significantly difference with scrum AFP (se-AFP). The AUC was 0.864 as u-AFP and u-ORM1 were combined, and they performed much better than u-AFP or u-ORM1 alone. Qualitative diagnostic analysis showed that the positive predictive value of u-AFP was 90.1% and the diagnostic sensitivity of parallel combination of u-AFP and u-ORM1 was 85.1%. Taken together, AFP and ORM1 in the urine may be used as a diagnostic or screening biomarker of HCC, and studies on large samples are needed to validate the result. NEW & NOTEWORTHY This study provides a novel way to find biomarkers of hepatocellular carcinoma (HCC) and a new perspective of alpha-fetoprotein clinical application. The urine reagent strips may be helpful in high epidemic areas of HCC and in low-resource settings.
引用
收藏
页码:G305 / G312
页数:8
相关论文
共 50 条
  • [41] Tackling hepatitis B virus-associated hepatocellular carcinoma-the future is now
    Bharadwaj, Mausumi
    Roy, Gaurav
    Dutta, Koushik
    Misbah, Mohammad
    Husain, Mohammad
    Hussain, Showket
    CANCER AND METASTASIS REVIEWS, 2013, 32 (1-2) : 229 - 268
  • [42] Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma
    Wang, Wen
    Zhao, Lan Juan
    Tan, Ye Xiong
    Ren, Hao
    Qi, Zhong-Tian
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (38) : 5442 - 5453
  • [43] Clinicopathological study of occult hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma
    El-Maksoud, Mohamed A.
    Habeeb, Maha R.
    Ghazy, Hayam F.
    Nomir, Manal M.
    Elalfy, Hatem
    Abed, Sally
    Zaki, Maysaa E. S.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (06) : 716 - 722
  • [44] Comparison of proteome between hepatitis B virus- and hepatitis C virus-associated hepatocellular carcinoma
    Kim, W
    Lim, SO
    Kim, JS
    Ryu, YH
    Byeon, JY
    Kim, HJ
    Kim, YI
    Heo, JS
    Park, YM
    Jung, GH
    CLINICAL CANCER RESEARCH, 2003, 9 (15) : 5493 - 5500
  • [45] Quantitative and statistical analysis of proteome in hepatitis B virus-associated hepatocellular carcinoma
    Li, C.
    Tan, Y. -X.
    Wang, H. -Y.
    Li, Y. -X.
    Wu, J. -R.
    Zeng, R.
    MOLECULAR & CELLULAR PROTEOMICS, 2006, 5 (10) : S221 - S221
  • [46] Hepatitis B virus-associated hepatocellular carcinoma: Study from Central India
    Chaudhary, Satyarth
    Thakur, Bhagwan Singh
    Jain, Sunil
    Jain, Neeraj
    Kumar, Ravindra
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 347 - 347
  • [47] Molecular mechanisms of gender disparity in hepatitis B virus-associated hepatocellular carcinoma
    Liu, Wei-Cheng
    Liu, Quan-Yan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (20) : 6252 - 6261
  • [48] Molecular mechanisms of gender disparity in hepatitis B virus-associated hepatocellular carcinoma
    Wei-Cheng Liu
    Quan-Yan Liu
    World Journal of Gastroenterology, 2014, (20) : 6252 - 6261
  • [50] Screening and validation of pivotal genes in hepatitis B virus-associated hepatocellular carcinoma
    武玉晶
    ChinaMedicalAbstracts(InternalMedicine), 2023, 40 (04) : 227 - 227